Athira Pharma, Inc(NASDAQ:ATHA) 
Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and stop neurodegradation. Its lead product candidate is ATH-1017, a blood brain barrier-penetrating, small hepatocyte growth factor/MET activator that is in LIFT-AD...
Website: http://www.athira.com
Founded: 2011
CEO: Leen Kawas
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 2.80
H 2.80
L 2.50
C 2.50
V 201,756
10EMA 2.50
20EMA 2.50
60EMA 2.50
120EMA 2.50
250EMA 2.50